Lumos Diagnostics Holdings (ASX:LDX) Gross Margin % : 51.89% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Lumos Diagnostics Holdings Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Lumos Diagnostics Holdings's Gross Profit for the six months ended in Dec. 2023 was A$2.14 Mil. Lumos Diagnostics Holdings's Revenue for the six months ended in Dec. 2023 was A$4.13 Mil. Therefore, Lumos Diagnostics Holdings's Gross Margin % for the quarter that ended in Dec. 2023 was 51.89%.

The historical rank and industry rank for Lumos Diagnostics Holdings's Gross Margin % or its related term are showing as below:

ASX:LDX' s Gross Margin % Range Over the Past 10 Years
Min: 38.32 Med: 47.51 Max: 59.72
Current: 59.72

During the past 2 years, the highest Gross Margin % of Lumos Diagnostics Holdings was 59.72%. The lowest was 38.32%. And the median was 47.51%.

ASX:LDX's Gross Margin % is ranked better than
66.35% of 211 companies
in the Medical Diagnostics & Research industry
Industry Median: 46.71 vs ASX:LDX: 59.72

Lumos Diagnostics Holdings had a gross margin of 51.89% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Lumos Diagnostics Holdings was 0.00% per year.

Lumos Diagnostics Holdings Gross Margin % Historical Data

The historical data trend for Lumos Diagnostics Holdings's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lumos Diagnostics Holdings Gross Margin % Chart

Lumos Diagnostics Holdings Annual Data

Trend

Jun22

Jun23

Gross Margin %

38.32

56.69

Lumos Diagnostics Holdings Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Gross Margin %	Get a 7-Day Free Trial			46.17	34.54	49.16	63.71	51.89

Competitive Comparison of Lumos Diagnostics Holdings's Gross Margin %

For the Diagnostics & Research subindustry, Lumos Diagnostics Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lumos Diagnostics Holdings's Gross Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Lumos Diagnostics Holdings's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Lumos Diagnostics Holdings's Gross Margin % falls into.

Lumos Diagnostics Holdings Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Lumos Diagnostics Holdings's Gross Margin for the fiscal year that ended in Jun. 2023 is calculated as

Gross Margin % (A: Jun. 2023 )	=	Gross Profit (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	8.9	/	15.697
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(15.697 - 6.799)	/	15.697
	=	56.69 %

Lumos Diagnostics Holdings's Gross Margin for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )	=	Gross Profit (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	2.1	/	4.132
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(4.132 - 1.988)	/	4.132
	=	51.89 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Lumos Diagnostics Holdings (ASX:LDX) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Lumos Diagnostics Holdings had a gross margin of 51.89% for the quarter that ended in Dec. 2023 => Durable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Lumos Diagnostics Holdings Gross Margin % Related Terms

Thank you for viewing the detailed overview of Lumos Diagnostics Holdings's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Lumos Diagnostics Holdings (ASX:LDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lumos Diagnostics Holdings Ltd (ASX:LDX) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

LDXHF:USA

Address

2724 Loker Ave West, Carlsbad, CA, USA, 92010

Website

https://www.lumosdiagnostics.com

Lumos Diagnostics Holdings Ltd is engaged in the development, manufacture and distribution of point-of-care diagnostic (POC) tests and associated readers for analysis of POC diagnostic tests. It also directly develops, manufactures and commercializes proprietary, Lumos-branded POC tests that target infectious and inflammatory diseases. It generates maximum revenue from the commercial services and solutions relating to POC diagnostic tests.

Lumos Diagnostics Holdings (ASX:LDX) Headlines

No Headlines